Alergia Imunopatologia FMUSP
Alergia Imunopatologia FMUSP
  • 196
  • 495 073
Chemsex, já ouviu falar? - Respire / É de lei
XIV Curso Avançado de Patogênese do HIV.
มุมมอง: 900

วีดีโอ

Métodos de avaliação do sistema imune: Aspectos moleculares - Juliana Zanatta30:47Métodos de avaliação do sistema imune: Aspectos moleculares - Juliana Zanatta
Métodos de avaliação do sistema imune: Aspectos moleculares - Juliana Zanatta
มุมมอง 4814 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Métodos de avaliação do sistema imune: Aspectos celulares - Andrea Niquirilo23:38Métodos de avaliação do sistema imune: Aspectos celulares - Andrea Niquirilo
Métodos de avaliação do sistema imune: Aspectos celulares - Andrea Niquirilo
มุมมอง 6394 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Ciclo replicativo do HIV - Lúcio Gama1:17:58Ciclo replicativo do HIV - Lúcio Gama
Ciclo replicativo do HIV - Lúcio Gama
มุมมอง 11K4 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Vaccine efficacy using a recombinant herpesvirus with near-full-length SIV genome-Ronald Desrosiers46:53Vaccine efficacy using a recombinant herpesvirus with near-full-length SIV genome-Ronald Desrosiers
Vaccine efficacy using a recombinant herpesvirus with near-full-length SIV genome-Ronald Desrosiers
มุมมอง 10K4 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
HIV and aging: role of the microbiome - Alan Landay53:27HIV and aging: role of the microbiome - Alan Landay
HIV and aging: role of the microbiome - Alan Landay
มุมมอง 4604 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Inflammatory defenses are not for the faint of HAART - Michael Lederman50:52Inflammatory defenses are not for the faint of HAART - Michael Lederman
Inflammatory defenses are not for the faint of HAART - Michael Lederman
มุมมอง 2234 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
B cell analyses in HIV clinical trials: do you have to kiss a lot of frogs? - Adrian McDermott49:29B cell analyses in HIV clinical trials: do you have to kiss a lot of frogs? - Adrian McDermott
B cell analyses in HIV clinical trials: do you have to kiss a lot of frogs? - Adrian McDermott
มุมมอง 4744 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
HIV cure: challenges and solutions - Rafick Sekaly57:55HIV cure: challenges and solutions - Rafick Sekaly
HIV cure: challenges and solutions - Rafick Sekaly
มุมมอง 1.4K4 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
HIV-1 Env glycoprotein trimers as a vaccine candidates - John Moore45:41HIV-1 Env glycoprotein trimers as a vaccine candidates - John Moore
HIV-1 Env glycoprotein trimers as a vaccine candidates - John Moore
มุมมอง 1K4 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Conventional HIV vaccines: any hope? - David Watkins38:10Conventional HIV vaccines: any hope? - David Watkins
Conventional HIV vaccines: any hope? - David Watkins
มุมมอง 4014 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Using antibodies against HIV - Rebecca Lynch48:45Using antibodies against HIV - Rebecca Lynch
Using antibodies against HIV - Rebecca Lynch
มุมมอง 4744 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
When to start: revisiting START, same-day initiation, and TasP - Mauro Schechter44:45When to start: revisiting START, same-day initiation, and TasP - Mauro Schechter
When to start: revisiting START, same-day initiation, and TasP - Mauro Schechter
มุมมอง 2904 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
Discovery of neutralizing monoclonal antibodies against infectious diseases - David Matkins30:04Discovery of neutralizing monoclonal antibodies against infectious diseases - David Matkins
Discovery of neutralizing monoclonal antibodies against infectious diseases - David Matkins
มุมมอง 2544 ปีที่แล้ว
XIV Curso Avançado de Patogênese do HIV.
STING controlled innmate immunity in HIV infectious disease, inflammation and cancer - Glen Barber44:39STING controlled innmate immunity in HIV infectious disease, inflammation and cancer - Glen Barber
STING controlled innmate immunity in HIV infectious disease, inflammation and cancer - Glen Barber
มุมมอง 1.1K4 ปีที่แล้ว
STING controlled innmate immunity in HIV infectious disease, inflammation and cancer - Glen Barber
Development of vaccines for emerging infectious diseases - Barney Graham1:01:12Development of vaccines for emerging infectious diseases - Barney Graham
Development of vaccines for emerging infectious diseases - Barney Graham
มุมมอง 1.1K4 ปีที่แล้ว
Development of vaccines for emerging infectious diseases - Barney Graham
Effect of Rapid ART initiation on HIV reservoir composition in HIV1 infected neonates-Dan Kuritzkies55:15Effect of Rapid ART initiation on HIV reservoir composition in HIV1 infected neonates-Dan Kuritzkies
Effect of Rapid ART initiation on HIV reservoir composition in HIV1 infected neonates-Dan Kuritzkies
มุมมอง 3324 ปีที่แล้ว
Effect of Rapid ART initiation on HIV reservoir composition in HIV1 infected neonates-Dan Kuritzkies
How to present a poster and write a manuscript - Douglas Nixon36:46How to present a poster and write a manuscript - Douglas Nixon
How to present a poster and write a manuscript - Douglas Nixon
มุมมอง 2114 ปีที่แล้ว
How to present a poster and write a manuscript - Douglas Nixon
Chamada CAPHIV 2020.2:50Chamada CAPHIV 2020.
Chamada CAPHIV 2020.
มุมมอง 3584 ปีที่แล้ว
Chamada CAPHIV 2020.
Strategies to cure HIV infection - Mario Stevenson53:04Strategies to cure HIV infection - Mario Stevenson
Strategies to cure HIV infection - Mario Stevenson
มุมมอง 1.9K4 ปีที่แล้ว
Strategies to cure HIV infection - Mario Stevenson
Tratamento do HIV e resistência - Luiz Zanella1:00:22Tratamento do HIV e resistência - Luiz Zanella
Tratamento do HIV e resistência - Luiz Zanella
มุมมอง 12K4 ปีที่แล้ว
Tratamento do HIV e resistência - Luiz Zanella
História natural da infecção pelo HIV - Ricardo Vasconselos59:06História natural da infecção pelo HIV - Ricardo Vasconselos
História natural da infecção pelo HIV - Ricardo Vasconselos
มุมมอง 10K4 ปีที่แล้ว
História natural da infecção pelo HIV - Ricardo Vasconselos
Revisão geral do sistema imune em doenças infecciosas - Esper Kallas49:42Revisão geral do sistema imune em doenças infecciosas - Esper Kallas
Revisão geral do sistema imune em doenças infecciosas - Esper Kallas
มุมมอง 2.6K5 ปีที่แล้ว
Revisão geral do sistema imune em doenças infecciosas - Esper Kallas
Abertura - Esper Kallas, Tarcisio Barros Filho8:28Abertura - Esper Kallas, Tarcisio Barros Filho
Abertura - Esper Kallas, Tarcisio Barros Filho
มุมมอง 1515 ปีที่แล้ว
Abertura - Esper Kallas, Tarcisio Barros Filho
Experiências vividas na epidemia - Drauzio Varella48:58Experiências vividas na epidemia - Drauzio Varella
Experiências vividas na epidemia - Drauzio Varella
มุมมอง 5345 ปีที่แล้ว
Experiências vividas na epidemia - Drauzio Varella
MHC class I antigen presentation in viral host defense - Ken Rock46:35MHC class I antigen presentation in viral host defense - Ken Rock
MHC class I antigen presentation in viral host defense - Ken Rock
มุมมอง 2495 ปีที่แล้ว
MHC class I antigen presentation in viral host defense - Ken Rock
Situação atual da epidemia de HIV/Aids no Brasil - Gerson Pereira55:02Situação atual da epidemia de HIV/Aids no Brasil - Gerson Pereira
Situação atual da epidemia de HIV/Aids no Brasil - Gerson Pereira
มุมมอง 2.2K5 ปีที่แล้ว
Situação atual da epidemia de HIV/Aids no Brasil - Gerson Pereira
OL-10 controls immynity to vaccines and infections - Mario Stevenson53:21OL-10 controls immynity to vaccines and infections - Mario Stevenson
OL-10 controls immynity to vaccines and infections - Mario Stevenson
มุมมอง 1596 ปีที่แล้ว
OL-10 controls immynity to vaccines and infections - Mario Stevenson
Traffic and how to beat it - Michael Lederman33:35Traffic and how to beat it - Michael Lederman
Traffic and how to beat it - Michael Lederman
มุมมอง 986 ปีที่แล้ว
Traffic and how to beat it - Michael Lederman
Can CD8+ T-cells or natural killer cells be harnessed to eliminate persistent HIV reservoirs?51:28Can CD8+ T-cells or natural killer cells be harnessed to eliminate persistent HIV reservoirs?
Can CD8+ T-cells or natural killer cells be harnessed to eliminate persistent HIV reservoirs?
มุมมอง 6116 ปีที่แล้ว
Can CD8 T-cells or natural killer cells be harnessed to eliminate persistent HIV reservoirs?